COVID-19 Severity Associates with Pulmonary Redistribution of CD1c+ DC and Inflammatory Transitional and Nonclassical Monocytes

Investigators studied the frequencies and activation profiles of dendritic cells and monocytes present in the blood and lung of COVID-19 patients with different clinical severity in comparison with healthy individuals.
[Journal of Clinical Investigation]
Sánchez-Cerrillo, I., Landete, P., Aldave, B., Sánchez-Alonso, S., Sánchez-Azofra, A., Marcos-Jiménez, A., Ávalos, E., Alcaraz-Serna, A., Santos, I. de los, Mateu-Albero, T., Esparcia, L., López-Sanz, C., Martínez-Fleta, P., Gabrie, L., Guerola, L. del C., Fuente, H. de la, Calzada, M. J., González-Álvaro, I., Alfranca, A., … Martín-Gayo, E. (2020). COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI140335 Cite
AbstractFull Article

Continue reading “COVID-19 Severity Associates with Pulmonary Redistribution of CD1c+ DC and Inflammatory Transitional and Nonclassical Monocytes”

Bookmark

No account yet? Register

0
Share

cDC1 Prime and Are Licensed by CD4+ T Cells to Induce Anti-Tumour Immunity

Early priming of CD4+ T cells against tumor-derived antigens required cDC1, and this was not simply because they transport antigens to lymph nodes for processing by cDC2, as selective deletion of major histocompatibility class II molecules in cDC1 also prevented early CD4+ T cell priming.
[Nature]
Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T., Bagadia, P., Liu, T., Briseño, C. G., Li, L., Gillanders, W. E., Wu, G. F., Yokoyama, W. M., Murphy, T. L., Schreiber, R. D., & Murphy, K. M. (2020). cDC1 prime and are licensed by CD4 + T cells to induce anti-tumour immunity. Nature, 1–6. https://doi.org/10.1038/s41586-020-2611-3 Cite
Abstract

Continue reading “cDC1 Prime and Are Licensed by CD4+ T Cells to Induce Anti-Tumour Immunity”

Bookmark

No account yet? Register

0
Share

Antitumor Dendritic Cell Vaccination in a Priming and Boosting Approach

The authors believe that currently available strategies for vaccines that target dendritic cells or use them to present antitumor antigens could be integrated into existing clinical practice using prime–boost approaches.
[Nature Reviews Drug Discovery]
Harari, A., Graciotti, M., Bassani-Sternberg, M., & Kandalaft, L. E. (2020). Antitumour dendritic cell vaccination in a priming and boosting approach. Nature Reviews Drug Discovery, 1–18. https://doi.org/10.1038/s41573-020-0074-8 Cite
Abstract

Continue reading “Antitumor Dendritic Cell Vaccination in a Priming and Boosting Approach”

Bookmark

No account yet? Register

0
Share

Bone Marrow-Derived Myeloid Progenitors as Driver Mutation Carriers in High- and Low-Risk Langerhans Cell Histiocytosis

Investigators examined the CD34+c-Kit+Flt3+ myeloid progenitor population as potential mutation carrier in all langerhans cell histiocytosis disease manifestations.
[Blood]
Abstract

Continue reading “Bone Marrow-Derived Myeloid Progenitors as Driver Mutation Carriers in High- and Low-Risk Langerhans Cell Histiocytosis”

Bookmark

No account yet? Register

0
Share

Interplay between SARS-CoV-2 and the Type I Interferon Response

Scientists describe our current knowledge of the complex interplay between SARS-CoV-2 infection and the IFN system, highlighting some of the gaps that need to be filled for a better understanding of the underlying molecular mechanisms.
[PLoS Pathogens]
Ribero, M. S., Jouvenet, N., Dreux, M., & Nisole, S. (2020). Interplay between SARS-CoV-2 and the type I interferon response. PLOS Pathogens, 16(7), e1008737. https://doi.org/10.1371/journal.ppat.1008737 Cite
Full Article

Continue reading “Interplay between SARS-CoV-2 and the Type I Interferon Response”

Bookmark

No account yet? Register

0
Share

Targeting HIV Env Immunogens to B Cell Follicles in Nonhuman Primates through Immune Complex or Protein Nanoparticle Formulations

Investigators demonstrated two strategies to concentrate HIV envelope immunogens in follicles, via the formation of immune complexes or by employing self-assembling protein nanoparticles for multivalent display of envelope antigens.
[NPJ Vaccines]
Martin, J. T., Cottrell, C. A., Antanasijevic, A., Carnathan, D. G., Cossette, B. J., Enemuo, C. A., Gebru, E. H., Choe, Y., Viviano, F., Fischinger, S., Tokatlian, T., Cirelli, K. M., Ueda, G., Copps, J., Schiffner, T., Menis, S., Alter, G., Schief, W. R., Crotty, S., … Irvine, D. J. (2020). Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations. Npj Vaccines, 5(1), 1–15. https://doi.org/10.1038/s41541-020-00223-1 Cite
Full Article

Continue reading “Targeting HIV Env Immunogens to B Cell Follicles in Nonhuman Primates through Immune Complex or Protein Nanoparticle Formulations”

Bookmark

No account yet? Register

0
Share

Mitoxantrone Triggers Immunogenic Prostate Cancer Cell Death via p53-Dependent PERK Expression

Immunogenic cell death was determined by assessing the release of damage-associated molecular patterns in the prostate cancer-derived cell lines LNCaP, 22RV1 and PC-3.
[Cellular Oncology]
Abstract

Continue reading “Mitoxantrone Triggers Immunogenic Prostate Cancer Cell Death via p53-Dependent PERK Expression”

Bookmark

No account yet? Register

0
Share

Toll-Like Receptor Dual-Acting Agonists Are Potent Inducers of PBMC-Produced Cytokines That Inhibit Hepatitis B Virus Production in Primary Human Hepatocytes

Researchers found that conditioned media (CM) from peripheral blood mononuclear cells (PBMCs) stimulated with dual-acting TLR7/8 and TLR2/7 agonists were more potent drivers of inhibition of hepatisis e and hepatitis s antigen secretion from hepatitis B virus-infected primary human hepatocytes than CM from PBMCs stimulated with single-acting TLR7 or TLR9 agonists.
[Scientific Reports]
Janovec, V., Hodek, J., Clarova, K., Hofman, T., Dostalik, P., Fronek, J., Chlupac, J., Chaperot, L., Durand, S., Baumert, T. F., Pichova, I., Lubyova, B., Hirsch, I., & Weber, J. (2020). Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes. Scientific Reports, 10(1), 12767. https://doi.org/10.1038/s41598-020-69614-7 Cite
Full Article

Continue reading “Toll-Like Receptor Dual-Acting Agonists Are Potent Inducers of PBMC-Produced Cytokines That Inhibit Hepatitis B Virus Production in Primary Human Hepatocytes”

Bookmark

No account yet? Register

0
Share

Long-Lasting Severe Immune Dysfunction in Ebola Virus Disease Survivors

Compared with healthy donors, ebola virus disease (EVD) survivors exhibited increased markers of blood markers of inflammation, intestinal tissue damage, T cell and B cell activation and a depletion of circulating dendritic cells.
[Nature Communications]
Full Article

Continue reading “Long-Lasting Severe Immune Dysfunction in Ebola Virus Disease Survivors”

Bookmark

No account yet? Register

0
Share

Oropouche Virus Infects, Persists and Induces IFN Response in Human Peripheral Blood Mononuclear Cells as Identified by RNA PrimeFlow™ and qRT-PCR Assays

Researchers observed Oropouche orthobunyavirus replication in human leukocytes lineages as THP-1 monocytes, Jeko-1 B cells and Jurkat T cells. Cell viability and viral particle detection were maintained in these cells, even after successive passages.
[Viruses]
Full ArticleGraphical Abstract

Continue reading “Oropouche Virus Infects, Persists and Induces IFN Response in Human Peripheral Blood Mononuclear Cells as Identified by RNA PrimeFlow™ and qRT-PCR Assays”

Bookmark

No account yet? Register

0
Share

Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation

The knockdown of the hematopoietic cell–specific transcription factors PU.1 and IRF4 decreased PD-L2 expression in GM-CSF-induced mouse bone marrow–derived dendritic cells.
[Journal of Immunology]
AbstractPress Release

Continue reading “Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation”

Bookmark

No account yet? Register

0
Share

Single-Cell Transcriptomics Reveals Regulators Underlying Immune Cell Diversity and Immune Subtypes Associated with Prognosis in Nasopharyngeal Carcinoma

Investigators revealed malignant signatures capturing intratumoral transcriptional heterogeneity and predicting aggressiveness of malignant cells. Diverse immune cell subtypes were identified, including novel subtypes such as CLEC9A+ dendritic cells
[Cell Research]
Full Article

Continue reading “Single-Cell Transcriptomics Reveals Regulators Underlying Immune Cell Diversity and Immune Subtypes Associated with Prognosis in Nasopharyngeal Carcinoma”

Bookmark

No account yet? Register

0
Share
Share